Journal article
HPV genoprevalence and HPV knowledge in young women in Mongolia, five years following a pilot 4vHPV vaccination campaign
T Batmunkh, C von Mollendorf, K Tulgaa, U Surenjav, MT Dalmau, N Namjil, B Tsedevdamba, S Tsegmed, J Enkhmaa, SM Garland, K Mulholland
Papillomavirus Research | ELSEVIER | Published : 2019
Abstract
Background: In a 2012 pilot, 9111 Mongolian girls aged 11–17 years received three doses of the quadrivalent (4vHPV) vaccine, Gardasil®. This is the first study to measure early vaccine effectiveness and assess knowledge and attitudes of young women in Mongolia in relation to the human papillomavirus (HPV), the vaccine and cervical cancer. Methods: A cohort of women vaccinated in 2012 (n = 726) and an unvaccinated cohort (n = 790) provided self-administered vaginal swabs for detection of high-risk HPV genotypes 16, 18/45, 31, 33, 35, 39, 51, 52, 56, 58, 59, 66, 68 five years following vaccination. Participant knowledge and attitudes were assessed through a questionnaire. Results: A total of 1..
View full abstractGrants
Awarded by Merck
Funding Acknowledgements
Co-funding was provided by the Australian Department of Foreign Affairs and Trade Direct Aid Program (Grant ID: ULNB/2016-2017/003), the Murdoch Children's Research Institute and the World Health Organization, Mongolia office (Grant ID: 201594897, WPMNG1611473). The Australian Department of Foreign Affairs and Trade and the World Health Organization had no involvement in the study process. Researchers at the Murdoch Children's Research Institute provided support on study design, data analysis and interpretation.